Association between the ERCC1 polymorphism and platinum-based chemotherapy effectiveness in ovarian cancer: a meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association between the ERCC1 polymorphism and platinum-based chemotherapy effectiveness in ovarian cancer: a meta-analysis

Published:2017-06-17 Issue:1 Volume:17 Page:
ISSN:1472-6874
Container-title:BMC Women's Health
language:en
Short-container-title:BMC Women's Health

Author:

Tang Ning,Lyu Dan,Zhang Yan,Liu Haiping^ORCID

Funder

President Funding of Jinan Military General Hospital

PLA General Logistics Department of the Ministry of Health

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,Reproductive Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12905-017-0393-z.pdf

Reference32 articles.

1. (WHO) WHO: Global cancer rates could increase by 50% to 15 million by 2020. 2003.

2. Yu JJ, Mu C, Lee KB, Okamoto A, Reed EL, Bostick-Bruton F, et al. A nucleotide polymorphism in ERCC1 in human ovarian cancer cell lines and tumor tissues. Mut Res/Mutation Res Genomics. 1997;382(1–2):13–20.

3. Yan L, Pei H, Yu C, Gui-ying W, Na W, Rong-miao Z. Predicting the outcome of platinum-based chemotherapies in epithelial ovarian cancer using the 8092C/a polymorphism of ERCC1: a meta-analysis. Biomarkers. 2014;19(2):128–34.

4. Gossage L, Madhusudan S. Current status of excision repair cross complementing-group 1 (ERCC1) in cancer. Cancer Treat Rev. 2007;33(6):565–77.

5. Reed E, Larkins TL, Chau CH, Figg WD. DNA Repair: ERCC1. Nucleotide Excision Repair Platinum Resistance. 2014:333–49.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual‑regulated oncolytic adenovirus carrying ERCC1‑siRNA gene possesses potent antitumor effect on ovarian cancer cells;Molecular Medicine Reports;2024-05-15

2. Therapeutic drug monitoring of selected anticancer drugs;Therapeutic Drug Monitoring;2024

3. Effect of ERCC1 polymorphisms on the response to platinum-based chemotherapy: A systematic review and meta-analysis based on Asian population;PLOS ONE;2023-05-04

4. Predictive Value of ERCC1 mRNA Level from Receiver-Operator Characteristic and Pretreatment EBV-DNA Virus Load in Stage II Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy with Concurrent Cisplatin;Cancer Biotherapy and Radiopharmaceuticals;2022-02-01

5. ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in patients with ovarian cancer: a systematic review and meta-analysis;Journal of Ovarian Research;2021-06-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3